Prevalence of molecular markers associated with Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in three malaria endemic local areas of Benue State, Nigeria
- PMID: 40519805
- PMCID: PMC12165245
- DOI: 10.11604/pamj.2025.50.73.45826
Prevalence of molecular markers associated with Plasmodium falciparum resistance to chloroquine and sulphadoxine/pyrimethamine in three malaria endemic local areas of Benue State, Nigeria
Abstract
Introduction: currently, malaria (primarily caused by Plasmodium falciparum) remains prevalent in over 106 countries and is one of the most severe public health problems globally, leading the cause of deaths especially among children and pregnant women particularly in developing countries. This study determined the drug-resistance molecular markers in Plasmodium falciparum infection in three malaria endemic local areas of Benue State, North-central Nigeria between June 2023 and September 2024.
Methods: the conclusive diagnosis of P. falciparum was based on identifying the characteristic asexual stage of the parasite in Giemsa-stained blood smears examined under a compound microscope. The DNA (Deoxyribonucleic acid) extraction from P. falciparum positive blood samples was done using Chelex extraction method. Nested polymerase chain reaction followed by Restriction Fragment Length Polymorphisms (PCR/RFLP) were used for the detection of Plasmodium falciparum Chloroquine resistance transporter (pfcrt), P. falciparum multidrug resistance 1 (pfmdr1), P. falciparum dihydrofolate reductase (pfdhfr) and P. falciparum dihydropteroate synthase (pfdhps). Data were analysed using SPSS Version 24.00 and inferences were drawn for Statistical significance at P<0.05.
Results: the results revealed well-characterized molecular markers of P. falciparum resistance to the 4-aminoquinolines and the antifolate drugs indicating a high prevalence of resistance: 41%, 60%, 51% and 47% of P. falciparum isolates at codons N86Y, K76T, S108N, N51I and A437G respectively.
Conclusion: the prevalence of resistance of isolates to antimalarial drugs was significantly high. Therefore, strategies to reduce multiple-strain infections should be implemented to improve antimalarial drug efficacy and reduce the rate of spread of drug resistance.
Keywords: Nigeria; Plasmodium falciparum; Prevalence; molecular markers; resistance.
Copyright: Amase Nyamngee et al.
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.Malar J. 2013 Aug 29;12:300. doi: 10.1186/1475-2875-12-300. Malar J. 2013. PMID: 23988011 Free PMC article.
-
Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.Malar J. 2022 Dec 24;21(1):394. doi: 10.1186/s12936-022-04403-3. Malar J. 2022. PMID: 36566182 Free PMC article.
-
Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.Malar J. 2011 Jan 28;10:18. doi: 10.1186/1475-2875-10-18. Malar J. 2011. PMID: 21272384 Free PMC article.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Molecular assays for determining sulphadoxine-pyrimethamine drug resistance in India: a systematic review.Parasitol Res. 2022 Oct;121(10):2765-2774. doi: 10.1007/s00436-022-07623-3. Epub 2022 Aug 18. Parasitol Res. 2022. PMID: 35980472
References
-
- CDC Malaria Worldwide-Impact of Malaria 2012.
-
- Sarah K. A year Round Resource to Count Malaria Out. World Malaria Day. 2012.
-
- DHS Demographic and Health Survey. Malaria Situation in Nigeria USAID President´s Malaria Initiatives FY 2012 Malaria Operational Plan. 2011.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources